MEC Plus

Optimal Surgical Approach for Mesothelioma
Optimal Surgical Approach for Mesothelioma
Raja Flores, MD
Role of SHP2 Inhibitors Alone or in Combination
Role of SHP2 Inhibitors Alone or in Combination
Rachel Sanborn, MD
Strategies to Target Minimal Residual Disease
Strategies to Target Minimal Residual Disease
Christine M. Lovly, MD, PhD
Systemic Therapies for Mesothelioma
Systemic Therapies for Mesothelioma
Jorge E. Gomez, MD
Cancer and Thrombosis What is the Role of Direct Oral Anticoagulants?
Cancer and Thrombosis What is the Role of Direct Oral Anticoagulants?
Craig S Kitchens, MD, MACP
Cancer and Thrombosis: What is the Role of Direct Oral Anticoagulants?
Cancer and Thrombosis: What is the Role of Direct Oral Anticoagulants?
Craig S Kitchens, MD, MACP
Cancer-related Bleeding and Thrombosis
Cancer-related Bleeding and Thrombosis
Anjlee Mahajan, MD
Anticoagulation in Oncology: What’s New?
Anticoagulation in Oncology: What’s New?
Craig S. Kitchens, MD, MACP
Novel Therapies for Thymic Malignancies
Novel Therapies for Thymic Malignancies
Jonathan Riess, MD
Novel Advances for Thyroid Carcinoma and Thymoma
Novel Advances for Thyroid Carcinoma and Thymoma
Belisario Arango, MD
Management of Thyroid and Thymic Carcinomas
Management of Thyroid and Thymic Carcinomas
Belisario A Arango. MD
Thyroid Cancer & Thymic Carcinoma: Recent Advances
Thyroid Cancer & Thymic Carcinoma: Recent Advances
Raja Mudad, MD
Urothelial Cancers- New Strategies
Urothelial Cancers- New Strategies
Sandy Srinivas, MD
Urothelial Cancer: New Strategies
Urothelial Cancer: New Strategies
Chong-xian Pan - MD - PhD - MS